Case report: Successful treatment of refractory membranous nephropathy with telitacicept

Despite various treatment methods, the remission rate of membranous nephropathy remains limited. Refractory membranous nephropathy especially lacks effective treatment plans. Telitacicept achieves comprehensive inhibition of CD20-positive B cells, plasma cells, and T cells, thereby bringing new hope...

Full description

Bibliographic Details
Main Authors: Lei Zhang, Hua Jin, Dong Wang, Yiping Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1268929/full
_version_ 1827792610194882560
author Lei Zhang
Hua Jin
Dong Wang
Yiping Wang
author_facet Lei Zhang
Hua Jin
Dong Wang
Yiping Wang
author_sort Lei Zhang
collection DOAJ
description Despite various treatment methods, the remission rate of membranous nephropathy remains limited. Refractory membranous nephropathy especially lacks effective treatment plans. Telitacicept achieves comprehensive inhibition of CD20-positive B cells, plasma cells, and T cells, thereby bringing new hope to the treatment of membranous nephropathy and refractory membranous nephropathy. Here, we report a case of a 46-year-old man with membranous nephropathy. Although the combined treatment with glucocorticoid, tacrolimus, mycophenolate mofetil, cyclophosphamide, and rituximab was not successful, the patient achieved complete remission of urinary protein after glucocorticoid combined with telitacicept. This is the first report on the application of telitacicept in the treatment of membranous nephropathy, especially refractory membranous nephropathy. The application of telitacicept in the treatment of membranous nephropathy deserves further attention.
first_indexed 2024-03-11T18:05:32Z
format Article
id doaj.art-d477528ebca94e4da1b5387c01aa5e21
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-11T18:05:32Z
publishDate 2023-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-d477528ebca94e4da1b5387c01aa5e212023-10-17T07:41:36ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-10-011410.3389/fimmu.2023.12689291268929Case report: Successful treatment of refractory membranous nephropathy with telitaciceptLei ZhangHua JinDong WangYiping WangDespite various treatment methods, the remission rate of membranous nephropathy remains limited. Refractory membranous nephropathy especially lacks effective treatment plans. Telitacicept achieves comprehensive inhibition of CD20-positive B cells, plasma cells, and T cells, thereby bringing new hope to the treatment of membranous nephropathy and refractory membranous nephropathy. Here, we report a case of a 46-year-old man with membranous nephropathy. Although the combined treatment with glucocorticoid, tacrolimus, mycophenolate mofetil, cyclophosphamide, and rituximab was not successful, the patient achieved complete remission of urinary protein after glucocorticoid combined with telitacicept. This is the first report on the application of telitacicept in the treatment of membranous nephropathy, especially refractory membranous nephropathy. The application of telitacicept in the treatment of membranous nephropathy deserves further attention.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1268929/fullcase reportsuccessfultreatmentrefractory membranous nephropathytelitacicept
spellingShingle Lei Zhang
Hua Jin
Dong Wang
Yiping Wang
Case report: Successful treatment of refractory membranous nephropathy with telitacicept
Frontiers in Immunology
case report
successful
treatment
refractory membranous nephropathy
telitacicept
title Case report: Successful treatment of refractory membranous nephropathy with telitacicept
title_full Case report: Successful treatment of refractory membranous nephropathy with telitacicept
title_fullStr Case report: Successful treatment of refractory membranous nephropathy with telitacicept
title_full_unstemmed Case report: Successful treatment of refractory membranous nephropathy with telitacicept
title_short Case report: Successful treatment of refractory membranous nephropathy with telitacicept
title_sort case report successful treatment of refractory membranous nephropathy with telitacicept
topic case report
successful
treatment
refractory membranous nephropathy
telitacicept
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1268929/full
work_keys_str_mv AT leizhang casereportsuccessfultreatmentofrefractorymembranousnephropathywithtelitacicept
AT huajin casereportsuccessfultreatmentofrefractorymembranousnephropathywithtelitacicept
AT dongwang casereportsuccessfultreatmentofrefractorymembranousnephropathywithtelitacicept
AT yipingwang casereportsuccessfultreatmentofrefractorymembranousnephropathywithtelitacicept